These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 1345755

  • 1. Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immunodeficiency virus infection. A phase I/II study.
    Meng TC, Fischl MA, Boota AM, Spector SA, Bennett D, Bassiakos Y, Lai SH, Wright B, Richman DD.
    Ann Intern Med; 1992 Jan 01; 116(1):13-20. PubMed ID: 1345755
    [Abstract] [Full Text] [Related]

  • 2. Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complex.
    Skowron G, Bozzette SA, Lim L, Pettinelli CB, Schaumburg HH, Arezzo J, Fischl MA, Powderly WG, Gocke DJ, Richman DD, Pottage JC, Antoniskis D, McKinley GF, Hyslop NE, Ray G, Simon G, Reed N, LoFaro ML, Uttamchandani RB, Gelb LD, Sperber SJ, Murphy RL, Leedom JM, Grieco MH, Zachary J, Hirsch MS, Spector SA, Bigley J, Soo W, Merigan TC.
    Ann Intern Med; 1993 Mar 01; 118(5):321-30. PubMed ID: 8094279
    [Abstract] [Full Text] [Related]

  • 3. Zalcitabine compared with zidovudine in patients with advanced HIV-1 infection who received previous zidovudine therapy.
    Fischl MA, Olson RM, Follansbee SE, Lalezari JP, Henry DH, Frame PT, Remick SC, Salgo MP, Lin AH, Nauss-Karol C, Lieberman J, Soo W.
    Ann Intern Med; 1993 May 15; 118(10):762-9. PubMed ID: 8097082
    [Abstract] [Full Text] [Related]

  • 4. Lamivudine plus zidovudine compared with zalcitabine plus zidovudine in patients with HIV infection. A randomized, double-blind, placebo-controlled trial. North American HIV Working Party.
    Bartlett JA, Benoit SL, Johnson VA, Quinn JB, Sepulveda GE, Ehmann WC, Tsoukas C, Fallon MA, Self PL, Rubin M.
    Ann Intern Med; 1996 Aug 01; 125(3):161-72. PubMed ID: 8686973
    [Abstract] [Full Text] [Related]

  • 5. Zidovudine monotherapy versus zidovudine plus zalcitabine combination therapy in HIV-positive persons with CD4 cell counts 300-500 cells/mm3: a double-blind controlled trial. The M50003 Study Group Coordinating and Writing Committee.
    Moyle GJ, Bouza E, Antunes F, Smith D, Harris R, Warburg M, Walker M.
    Antivir Ther; 1997 Dec 01; 2(4):229-36. PubMed ID: 11327442
    [Abstract] [Full Text] [Related]

  • 6. Safety and efficacy of lamivudine-zidovudine combination therapy in zidovudine-experienced patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.
    Staszewski S, Loveday C, Picazo JJ, Dellarnonica P, Skinhøj P, Johnson MA, Danner SA, Harrigan PR, Hill AM, Verity L, McDade H.
    JAMA; 1996 Jul 10; 276(2):111-7. PubMed ID: 8656502
    [Abstract] [Full Text] [Related]

  • 7. A pilot study of low-dose zidovudine in human immunodeficiency virus infection.
    Collier AC, Bozzette S, Coombs RW, Causey DM, Schoenfeld DA, Spector SA, Pettinelli CB, Davies G, Richman DD, Leedom JM.
    N Engl J Med; 1990 Oct 11; 323(15):1015-21. PubMed ID: 1977080
    [Abstract] [Full Text] [Related]

  • 8. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.
    Fischl MA, Richman DD, Hansen N, Collier AC, Carey JT, Para MF, Hardy WD, Dolin R, Powderly WG, Allan JD.
    Ann Intern Med; 1990 May 15; 112(10):727-37. PubMed ID: 1970466
    [Abstract] [Full Text] [Related]

  • 9. Combination and monotherapy with zidovudine and zalcitabine in patients with advanced HIV disease. The NIAID AIDS Clinical Trials Group.
    Fischl MA, Stanley K, Collier AC, Arduino JM, Stein DS, Feinberg JE, Allan JD, Goldsmith JC, Powderly WG.
    Ann Intern Med; 1995 Jan 01; 122(1):24-32. PubMed ID: 7985892
    [Abstract] [Full Text] [Related]

  • 10. Zalcitabine.
    Shelton MJ, O'Donnell AM, Morse GD.
    Ann Pharmacother; 1993 Apr 01; 27(4):480-9. PubMed ID: 8097417
    [Abstract] [Full Text] [Related]

  • 11. Combination therapy with zidovudine and didanosine compared with zidovudine alone in HIV-1 infection.
    Collier AC, Coombs RW, Fischl MA, Skolnik PR, Northfelt D, Boutin P, Hooper CJ, Kaplan LD, Volberding PA, Davis LG, Henrard DR, Weller S, Corey L.
    Ann Intern Med; 1993 Oct 15; 119(8):786-93. PubMed ID: 8379600
    [Abstract] [Full Text] [Related]

  • 12. Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.
    Katlama C, Ingrand D, Loveday C, Clumeck N, Mallolas J, Staszewski S, Johnson M, Hill AM, Pearce G, McDade H.
    JAMA; 1996 Jul 10; 276(2):118-25. PubMed ID: 8656503
    [Abstract] [Full Text] [Related]

  • 13. Zidovudine-interferon-alpha combination therapy in patients with advanced human immunodeficiency virus type 1 infection: biphasic response of p24 antigen and quantitative polymerase chain reaction.
    Edlin BR, Weinstein RA, Whaling SM, Ou CY, Connolly PJ, Moore JL, Bitran JD.
    J Infect Dis; 1992 May 10; 165(5):793-8. PubMed ID: 1349031
    [Abstract] [Full Text] [Related]

  • 14. Dideoxycytidine alone and in an alternating schedule with zidovudine in children with symptomatic human immunodeficiency virus infection.
    Pizzo PA, Butler K, Balis F, Brouwers E, Hawkins M, Eddy J, Einloth M, Falloon J, Husson R, Jarosinski P.
    J Pediatr; 1990 Nov 10; 117(5):799-808. PubMed ID: 2172501
    [Abstract] [Full Text] [Related]

  • 15. A randomized controlled trial of a protease inhibitor (saquinavir) in combination with zidovudine in previously untreated patients with advanced HIV infection.
    Vella S, Lazzarin A, Carosi G, Sinicco A, Armignacco O, Angarano G, Andreoni M, Tambussi G, Chiodera A, Floridia M, Scaccabarozzi S, Facey K, Duncan I, Boudes P, Bragman K.
    Antivir Ther; 1996 Aug 10; 1(3):129-40. PubMed ID: 11322246
    [Abstract] [Full Text] [Related]

  • 16. [Sequential dideoxycytidine and zidovudine in advanced HIV-1 infection. Phase II study].
    Ruiz-Argüelles GJ, Lagunes-Yannelli B, Mercado-Díaz L.
    Rev Invest Clin; 1993 Aug 10; 45(2):145-7. PubMed ID: 8393211
    [Abstract] [Full Text] [Related]

  • 17. Zidovudine and lamivudine: results of phase III studies.
    Staszewski S.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Aug 10; 10 Suppl 1():S57. PubMed ID: 8595510
    [Abstract] [Full Text] [Related]

  • 18. AIDS Clinical Trials Group: phase I/II study of combination 2',3'-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex.
    Meng TC, Fischl MA, Richman DD.
    Am J Med; 1990 May 21; 88(5B):27S-30S. PubMed ID: 2159707
    [Abstract] [Full Text] [Related]

  • 19. Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017).
    Mulder JW, Cooper DA, Mathiesen L, Sandström E, Clumeck N, Gatell JM, French M, Donovan B, Gray F, Yeo JM.
    AIDS; 1994 Mar 21; 8(3):313-21. PubMed ID: 7913326
    [Abstract] [Full Text] [Related]

  • 20. Safety and activity of zalcitabine and zidovudine combination in HIV-positive people with CD4 cell counts < or = 300 cells/mm3. The Roche M50002 Study Group.
    Moyle GJ, Walker M, Harris R, Kellagher A, Warburg M.
    Antivir Ther; 1996 Aug 21; 1(3):180-8. PubMed ID: 11322252
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.